SPEECHVIVE, INC.
LAFAYETTE, IN · Founded 2011 · CIK 0001593767 · Medtech · Private
A wearable/portable device that provides auditory feedback to improve speech volume, articulation, and rate in Parkinson's disease patients, with accompanying telehealth platform for remote programmin
- Grants
- $1.3M
- 2 awards
- Sector median: 1
- Raised
- $280K
- 3 Form D · Apr 2020
- 78 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20132014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $750,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Telehealth Platform for Treatment with the SpeechVive Device | $597,381 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Telehealth Platform for Treatment with the SpeechVive Device | $654,719 | |
| Private capital raised | Form D · SEC | $280,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 981 | Nanosphere Health Sciences Inc. | — | $24M |
| 982 | Direct Allergy, LLC | — | $735K |
| 983 | ICHOR VASCULAR INC. | — | $3.1M |
| 984 | SPEECHVIVE, INC. | — | $280K |
| 985 | VIVAQUANT, LLC | — | $175K |
| 986 | CHITOGEN INC | — | $347K |
| 987 | Happy Cloud, Inc. | — | $4.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John HeretigDirector
- Jessica HuberDirector · Promoter
- Brian KoppExecutive Officer · Promoter
- Steve MogensenDirector · Executive Officer · Promoter
- Connell SeanDirector
- Bob StoreyDirector
- Keith WellsDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.